The clinical and economic burden of newly diagnosed alzheimer's disease in a medicare advantage population

American Journal of Alzheimer's Disease and other Dementias

Volumn 28, Issue 4, 2013, Pages 384-392

  Suehs, Brandon T ^a   Davis, Cralen D ^a   Alvir, Jose ^b   Van Amerongen, Derek ^c   Pharmd, Nick C Patel ^a   Joshi, Ashish V ^b   Faison, Warachal E ^b   Shah, Sonali N ^b  

^a Research Scientist   (United States)

^b PFIZER INC   (United States)

^c HUMANA INC   (United States)

Author keywords

Alzheimer's disease; comorbidity burden; cost of care; health care resource utilization; medicare

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; COMORBIDITY; CONTROLLED STUDY; DEMENTIA; FEMALE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HUMAN; ICD-9; MAJOR CLINICAL STUDY; MALE; MEDICARE; OBSERVATIONAL STUDY; PHARMACY; RETROSPECTIVE STUDY;

EID: 84879715181     PISSN: 15333175     EISSN: 19382731     Source Type: Journal    
DOI: 10.1177/1533317513488911     Document Type: Article

References (38)

1. 2012 Alzheimer's disease facts and figures. Alzheimers Dement. 2012 ; 8 (2). 131-168
2. Weiner M, Powe NR, Weller WE, Shaffer TJ, Anderson GF. Alzheimer's disease under managed care: implications from Medicare utilization and expenditure patterns. J Am Geriatr Soc. 1998 ; 46 (6). 762-770
3. Gutterman EM, Markowitz JS, Lewis B, Fillit H. Cost of Alzheimer's disease and related dementia in managed-medicare. J Am Geriatr Soc. 1999 ; 47 (9). 1065-1071
4. Menzin J, Lang K, Friedman M, Neumann P, Cummings JL. The economic cost of Alzheimer's disease and related dementias to the California medicaid program ("Medi-Cal") in 1995. Am J Geriatr Psychiatry. 1999 ; 7 (4). 300-308
5. Richards KM, Shepherd MD, Lynn Crismon M, Snyder EH, Jermain DM. Medical services utilization and charge comparisons between elderly patients with and without Alzheimer's disease in a managed care organization. Clin Ther. 2000 ; 22 (6). 775-791
6. Linkins K, Lloyd J. Treatment of Alzheimer's disease patients in a managed care organization: a descriptive study of costs and utilization. Drug Benefit Trends. 2000 ; 12 (3). 6
7. Martin BC, Ricci JF, Kotzan JA, Lang K, Menzin J. The net cost of Alzheimer disease and related dementia: a population-based study of Georgia medicaid recipients. Alzheimer Dis Assoc Disord. 2000 ; 14 (3). 151-159
8. Hill J, Futterman R, Duttagupta S, Mastey V, Lloyd J, Fillit H. Alzheimer's disease and related dementias increase costs of comorbidities in managed Medicare. Neurology. 2002 ; 58 (1). 62-70
9. Frytak JR, Henk HJ, Zhao Y, Bowman L, Flynn JA, Nelson M. Health service utilization among Alzheimer's disease patients: evidence from managed care. Alzheimers Dement. 2008 ; 4 (5). 361-367
10. Zhao Y, Kuo TC, Weir S, Kramer M, Ash A. Healthcare costs and utilization for medicare beneficiaries with Alzheimer's. BMC Health Serv Res. 2008 ; 8 (1). 108
11. Joyce AT, Zhao Y, Bowman L, Flynn JA, Carter CT, Ollendorf DA. Burden of illness among commercially insured patients with Alzheimer's disease. Alzheimers Dement. 2007 ; 3 (3). 204-210
12. Bynum JP, Rabins PV, Weller W, Niefeld M, Anderson GF, Wu AW. The relationship between a dementia diagnosis, chronic illness, Medicare expenditures, and hospital use. J Am Geriatr Soc. 2004 ; 52 (2). 187-194
13. Fillit H, Hill JW, Futterman R. Health care utilization and costs of Alzheimer's disease: the role of comorbid conditions, disease stage, and pharmacotherapy. Fam Med. 2002 ; 34 (7). 528-535
14. Bloom BS, De Pouvourville N, Straus WL. Cost of illness of Alzheimer's disease: how useful are current estimates?. Gerontologist. 2003 ; 43 (2). 158
15. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992 ; 45 (6). 613-619
16. Sloan KL, Sales AE, Liu CF, et al. Construction and characteristics of the RxRisk-V: a VA-adapted pharmacy-based case-mix instrument. Med Care. 2003 ; 41 (6). 761-774
17. Sales AE, Liu CF, Sloan KL, et al. Predicting costs of care using a pharmacy-based measure risk adjustment in a veteran population. Med Care. 2003 ; 41 (6). 753
18. Farley JF, Harley CR, Devine JW. A comparison of comorbidity measurements to predict healthcare expenditures. Am J Manag Care. 2006 ; 12 (2). 110-119
19. Blough DK, Ramsey SD. Using generalized linear models to assess medical care costs. Health Serv Outcome Res Methodol. 2000 ; 1 (2). 185-202
20. Duan N. Smearing estimate: a nonparametric retransformation method. J Am Stat Assoc. 1983 ; 78 (383). 605-610
21. Kuo TC, Zhao Y, Weir S, Kramer MS, Ash AS. Implications of comorbidity on costs for patients with Alzheimer disease. Med Care. 2008 ; 46 (8). 839-846
22. Albert SM, Glied S, Andrews H, Stern Y, Mayeux R. Primary care expenditures before the onset of Alzheimer's disease. Neurology. 2002 ; 59 (4). 573-578
23. Ramakers IH, Visser PJ, Aalten P, et al. Symptoms of preclinical dementia in general practice up to five years before dementia diagnosis. Dement Geriatr Cogn Disord. 2007 ; 24 (4). 300-306
24. Eisele M, van den Bussche H, Koller D, et al. Utilization patterns of ambulatory medical care before and after the diagnosis of dementia in Germany - results of a case-control study. Dement Geriatr Cogn Disord. 2010 ; 29 (6). 475-483
25. Emre M. Dementia associated with Parkinson's disease. Lancet Neurol. 2003 ; 2 (4). 229-237
26. Aggarwal NT, Wilson RS, Beck TL, Bienias JL, Bennett DA. Motor dysfunction in mild cognitive impairment and the risk of incident Alzheimer disease. Arch Neurol. 2006 ; 63 (12). 1763-1769
27. Scharfman HE. Alzheimer's disease and epilepsy: insight from animal models. Future Neurol. 2012 ; 7 (2). 177-192
28. Rosenberg PB, Mielke MM, Appleby BS, Oh ES, Geda YE, Lyketsos CG. The association of neuropsychiatric symptoms in MCI with incident dementia and Alzheimer disease [published online April 27, 2012]. Am J Geriatr Psychiatry. 2012 ;:
29. Borson S, Scanlan JM, Lessig M, DeMers S. Comorbidity in aging and dementia: scales differ, and the difference matters. Am J Geriatr Psychiatry. 2010 ; 18 (11). 999-1006
30. Lin PJ, Kaufer DI, Maciejewski ML, Ganguly R, Paul JE, Biddle AK. An examination of Alzheimer's disease case definitions using medicare claims and survey data. Alzheimers Dement. 2010 ; 6 (4). 334-341
31. Taylor DH, Fillenbaum GG, Ezell ME. The accuracy of medicare claims data in identifying Alzheimer's disease. J Clin Epidemiol. 2002 ; 55 (9). 929-937
32. Østbye T, Taylor DH, Clipp EC, Scoyoc LV, Plassman BL. Identification of dementia: agreement among national survey data, medicare claims, and death certificates. Health Serv Res. 2008 ; 43 (1 pt 1). 313-326
33. Newcomer R, Clay T, Luxenberg JS, Miller RH. Misclassification and selection bias when identifying Alzheimer's disease solely from Medicare claims records. J Am Geriatr Soc. 1999 ; 47 (2). 215-219
34. Fillit H, Geldmacher DS, Welter RT, Maslow K, Fraser M. Optimizing coding and reimbursement to improve management of Alzheimer's disease and related dementias. J Am Geriatr Soc. 2002 ; 50 (11). 1871-1878
35. Jacobs DM, Sano M, Dooneief G, Marder K, Bell K, Stern Y. Neuropsychological detection and characterization of preclinical Alzheimer's disease. Neurology. 1995 ; 45 (5). 957-962
36. Saxton J, Lopez O, Ratcliff G, et al. Preclinical Alzheimer disease. Neurology. 2004 ; 63 (12). 2341-2347
37. Small BJ, Fratiglioni L, Viitanen M, Winblad B, Backman L. The course of cognitive impairment in preclinical Alzheimer disease: three- and 6-year follow-up of a population-based sample. Arch Neurol. 2000 ; 57 (6). 839-844
38. Bäckman L, Jones S, Berger AK, Laukka EJ, Small BJ. Cognitive impairment in preclinical Alzheimer's disease: a meta-analysis. Neuropsychology. 2005 ; 19 (4). 520-531